Founders Capital Management Has $72,000 Position in Abbott Laboratories (NYSE:ABT)
Founders Capital Management reduced its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 30.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 748 shares of the healthcare product maker’s stock after selling 325 shares during the quarter. […]